Clinical Innovation, Research & Collaboration at JR Analytics

At JR Analytics, we believe meaningful digital health innovation must be grounded in real-world clinical practice and developed through close collaboration with healthcare services, academic institutions, and industry partners. Our work focuses on identifying practical challenges in emergency, pre-hospital, and critical care settings and exploring digital approaches that support safer, more effective clinical decision-making.

JR Analytics is founded and led by a clinician with over two decades of experience in intensive care and retrieval medicine. Our innovation activities are informed by direct frontline practice, with a strong emphasis on clinical relevance, usability, governance, and alignment with established guidelines and real-world workflows.

​

Active Research Areas

Our current research and innovation activities focus on clinically grounded digital solutions in high-acuity environments, including:

• • AI-assisted interpretation of thromboelastometry (ROTEM) traces to support haemostasis decision-making

  • Digital pre-hospital documentation and workflow optimisation to improve structured data capture and continuity of care

  • Early-stage development of predictive models using structured vital signs to explore anticipatory risk detection in emergency settings

​

The Clinical Problem

Emergency, prehospital, and critical care environments operate under extreme time pressure, high cognitive load, and clinical uncertainty. Clinicians must interpret multiple physiological signals and clinical inputs rapidly while delivering time-critical interventions.

Although health systems have become increasingly digitised, much of the data generated in these settings remains fragmented, inconsistently structured, or retrospectively analysed. Early physiological signals, particularly vital signs, are often recorded but underutilised for proactive risk identification. As a result, deterioration may only be recognised after escalation is required, and opportunities for earlier intervention are missed.

These challenges are particularly evident in prehospital care, massive transfusion and haemostasis management, and surge or disaster scenarios where rapid, informed decisions are essential.

​​The Innovation Opportunity

There is a clear opportunity to develop digital tools that support clinicians at the point of care without increasing cognitive burden. Effective solutions must prioritise speed, simplicity, and clinical relevance, while enabling structured data capture and early risk-informed insights during time-critical care.

JR Analytics explores clinician-informed, context-aware approaches to workflow design and decision-support that aim not only to improve documentation, but also to responsibly investigate how structured physiological data may support anticipatory clinical insight. Innovation is undertaken cautiously and iteratively, with strong emphasis on governance, evaluation, ethical design, and alignment with regulated healthcare environments.

​​

Evidence, Validation, Ethics & Governance (In Progress)

JR Analytics develops digital health solutions through a staged, evidence-informed approach that prioritises clinical safety, ethical design, transparency, and real-world applicability.

Innovation activities are structured to progress from early feasibility exploration to clinical validation, ensuring that emerging technologies, particularly AI-enabled approaches, are evaluated rigorously before implementation.

Current evidence and validation activities include:

• Use of simulated and de-identified clinical datasets for early model development, feasibility testing, and performance evaluation

• Clinician co-design informed by frontline experience in emergency, pre-hospital, and critical care environments

• Conference abstracts, academic collaborations, and research outputs in preparation or under submission

• Planned pilot and feasibility studies in collaboration with clinical services and academic partners

 

All research and collaborative initiatives are conducted in accordance with applicable ethics and governance requirements. Where required, projects operate under institutional Human Research Ethics Committee (HREC) approvals or equivalent governance frameworks.

Development activities align with relevant national and international standards relating to clinical safety, data governance, transparency in AI, and responsible digital health innovation. Particular attention is given to issues of bias, model validation, interpretability, and the appropriate role of decision-support tools in regulated healthcare environments.